EVOKE PHARMA, INC. Additional Paid in Capital
EVOKE PHARMA, INC. had Additional Paid in Capital of $44.71 million as of 2014-09-30, per its 10-Q filed 2014-11-13.
Discontinued › Balance Sheet › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapital · last filed 2014-11-13
- 2014-09-30: Additional Paid in Capital $44.71M.
- 2014-06-30: Additional Paid in Capital $44.36M.
- 2014-03-31: Additional Paid in Capital $44.10M.
- 2013-12-31: Additional Paid in Capital $43.87M.
| Period end | Additional Paid in Capital |
|---|---|
| 2014-09-30 | $44.71M 10-Q · filed 2014-11-13 |
| 2014-06-30 | $44.36M 10-Q · filed 2014-08-13 |
| 2014-03-31 | $44.10M 10-Q · filed 2014-05-13 |
| 2013-12-31 | $43.87M 10-Q · filed 2014-11-13 |
| 2013-09-30 | $40.30M 10-Q · filed 2013-11-13 |
| 2012-12-31 | $195.53K 10-K · filed 2014-03-25 |